Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02943226 · ClinicalTrials.gov registry record · NA

Effect of Three Side Hole Infusion Catheter on CT Image Quality Compared to a Standard Infusion Catheter

A NA study of Contrast Enhanced Computed Tomography (CT) Scanning, sponsored by The University of Texas Health Science Center, Houston.

Completed
Registry status
NA
Development phase
61
Enrollment target
1
Study location

NCT02943226 is a NA study of Contrast Enhanced Computed Tomography (CT) Scanning that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 61 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02943226, a NA study of Contrast Enhanced Computed Tomography (CT) Scanning, has completed, sponsored by The University of Texas Health Science Center, Houston.

COMPLETED
Registry status
NA
Development phase
61 participants
Enrollment target
1
Study location

Study Summary

The purpose of this research study is to compare two types of catheters used for infusing the contrast dye necessary for viewing internal organs during computed tomography (CT) scanning. The standard catheter, which has one hole from which contrast dye enters veins, will be compared to the Becton Dickinson Nexiva Diffusics System catheter, which has three holes for diffusing dye into veins. The purpose of this study is to determine which catheter type gives the best image.

Interventions

  • DEVICE Becton Dickinson Nexiva Diffusics System
  • DEVICE Standard intravenous catheter

Study Locations (1)

Texas

  • The University of Texas Health Science Center at Houston - Houston

Trial Details

FieldValue
Enrollment Target 61 participants
Start Date 2016-10
Est. Completion 2016-11
Phase NA

What the Registry Record Tells You About NCT02943226

The ClinicalTrials.gov registry entry for NCT02943226 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 61 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Contrast Enhanced Computed Tomography (CT) Scanning appearing as the primary indexed condition, and to 2 interventions - of which Becton Dickinson Nexiva Diffusics System is the first listed.

NCT02943226 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT02943226 about?

NCT02943226 is a clinical study titled "Effect of Three Side Hole Infusion Catheter on CT Image Quality Compared to a Standard Infusion Catheter". The purpose of this research study is to compare two types of catheters used for infusing the contrast dye necessary for viewing internal organs during computed tomography (CT) scanning. The standard catheter, which has one hole from which contrast dye enters veins, will be compared to the Becton Di...

What is the current status of trial NCT02943226?

This trial is currently completed. It is a NA study. The enrollment target is 61 participants. The study started on 2016-10. Estimated completion is 2016-11.

What conditions does trial NCT02943226 study?

This clinical trial studies the following conditions: Contrast Enhanced Computed Tomography (CT) Scanning.

What interventions are being tested in trial NCT02943226?

The interventions under investigation include: Becton Dickinson Nexiva Diffusics System (DEVICE), Standard intravenous catheter (DEVICE).

Who is sponsoring clinical trial NCT02943226?

This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02943226 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.